{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:36:08Z","timestamp":1784770568783,"version":"3.55.0"},"reference-count":36,"publisher":"American Veterinary Medical Association (AVMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To investigate the contribution of <jats:italic>gyrA<\/jats:italic> mutation and efflux pumps to fluoroquinolone resistance and multidrug resistance among <jats:italic>Escherichia coli<\/jats:italic> isolates from dogs and cats.<\/jats:p>\n<jats:p><jats:bold>Sample Population<\/jats:bold>\u2014536 clinical isolates of <jats:italic>E coli.<\/jats:italic><\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Minimum inhibitory concentrations (MICs) were determined for enrofloxacin and 6 other drug classes by use of broth microdilution techniques. Real-time PCR assay was used to determine the mutation in <jats:italic>gyrA<\/jats:italic>; Phe-Arg-\u03b2-naphthylamide, an efflux pump inhibitor, was used to examine the contribution of efflux pump overexpression.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014The MIC for fluoroquinolones increased in a stepwise fashion and was lowest in the absence of mutations, higher with a single point mutation, and highest with 2 point mutations. Level of resistance in the latter category was high (8 times the breakpoint), but this was associated with expression of the AcrAB efflux pump. Inhibition of the efflux pump resulted in a reduction in the MIC to less than the susceptible breakpoint for isolates with an MIC \u2264 4 mg\/L, regardless of the presence of a mutation. The greatest magnitude in MIC decrease (MIC was decreased by a factor of &gt; 67 fold) was for isolates with a single mutation but the greatest absolute decrease in MIC (124 mg\/L) was for isolates with 2 mutations. Inhibition of the AcrAB efflux pump in isolates characterized by multidrug resistance decreased the MIC of drugs structurally unrelated to fluoroquinolone.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Fluoroquinolone resistance in <jats:italic>E coli<\/jats:italic> appeared to be a stepwise phenomenon, with MIC increasing as the number of point mutations in <jats:italic>gyrA<\/jats:italic> increased, but high-level resistance and multidrug resistance associated with fluoroquinolone resistance reflected overexpression of the AcrAB efflux pump.<\/jats:p>","DOI":"10.2460\/ajvr.72.1.25","type":"journal-article","created":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T08:03:24Z","timestamp":1293869004000},"page":"25-32","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the contribution of gyrA mutation and efflux pumps to fluoroquinolone and multidrug resistance in pathogenic Escherichia coli isolates from dogs and cats"],"prefix":"10.2460","volume":"72","author":[{"given":"Bashar W.","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Boothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Oyarzabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Vet Microbiol","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0378-1135(03)00063-4","article-title":"Uropathogenic virulence factors in isolates of Escherichia coli from clinical cases of canine pyometra and feces of healthy bitches","volume":"94","author":"Chen","year":"2003"},{"key":"ref2","series-title":"Vet Microbiol","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-1135(01)00449-7","article-title":"Escherichia coli strains isolated from the uterus and urinary bladder of bitches suffering from pyometra: comparison by restriction enzyme digestion and pulsed-field gel electrophoresis","volume":"84","author":"Hagman","year":"2002"},{"key":"ref3","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2460\/javma.2002.220.190","article-title":"Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections","volume":"220","author":"Cooke","year":"2002"},{"key":"ref4","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jac\/dkh332","article-title":"Pet animals as reservoirs of antimicrobial-resistant bacteria","volume":"54","author":"Guardabassi","year":"2004"},{"key":"ref5","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1939-1676.2006.tb00742.x","article-title":"Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats","volume":"20","author":"Boothe","year":"2006"},{"key":"ref6","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jac\/46.2.223","article-title":"Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands","volume":"46","author":"Goettsch","year":"2000"},{"key":"ref7","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole-and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008"},{"key":"ref8","series-title":"J Clin Microbiol","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1128\/JCM.40.10.3586-3595.2002","article-title":"Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs","volume":"40","author":"Sanchez","year":"2002"},{"key":"ref9","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996"},{"issue":"suppl 2","key":"ref10","series-title":"Drugs","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: an update 1994\u20131998","volume":"58","author":"Piddock","year":"1999"},{"key":"ref11","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1128\/AAC.40.4.879","article-title":"Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli","volume":"40","author":"Heisig","year":"1996"},{"key":"ref12","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/jac\/47.3.341","article-title":"Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys","volume":"47","author":"Giraud","year":"2001"},{"key":"ref13","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jac\/38.3.443","article-title":"gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli","volume":"38","author":"Conrad","year":"1996"},{"key":"ref14","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1128\/AAC.38.10.2477","article-title":"Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs","volume":"38","author":"Vila","year":"1994"},{"key":"ref15","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.2174\/092986709787581879","article-title":"Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update","volume":"16","author":"Cattoir","year":"2009"},{"key":"ref16","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006"},{"key":"ref17","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1128\/AAC.00339-07","article-title":"New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate","volume":"51","author":"Yamane","year":"2007"},{"key":"ref18","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","article-title":"Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria","volume":"19","author":"Piddock","year":"2006"},{"key":"ref19","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/AAC.45.4.1126-1136.2001","article-title":"Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes","volume":"45","author":"Sulavik","year":"2001"},{"key":"ref20","series-title":"J Bacteriol","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1128\/jb.179.8.2512-2518.1997","article-title":"Active efflux of bile salts by Escherichia coli","volume":"179","author":"Thanassi","year":"1997"},{"key":"ref21","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1128\/AAC.44.12.3441-3443.2000","article-title":"High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA","volume":"44","author":"Mazzariol","year":"2000"},{"key":"ref22","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/AAC.49.2.565-570.2005","article-title":"Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa","volume":"49","author":"Kriengkauykiat","year":"2005"},{"key":"ref23","series-title":"Int J Antimicrob Agents","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2004.09.004","article-title":"A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets","volume":"24","author":"Meunier","year":"2004"},{"key":"ref24","series-title":"Performance standards for antimicrobial disk and dilution susceptibility testing for bacteria isolated from animals; approved standard","year":"2008"},{"key":"ref25","series-title":"Vet Microbiol","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.vetmic.2009.05.016","article-title":"Detection of fluoroquinolone resistance level in clinical canine and feline Escherichia coli pathogens using rapid real-time PCR assay","volume":"139","author":"Shaheen","year":"2009"},{"key":"ref26","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.37.1.126","article-title":"A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex","volume":"37","author":"Willmott","year":"1993"},{"key":"ref27","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001"},{"key":"ref28","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"Drlica","year":"2003"},{"key":"ref29","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/jac\/dkh360","article-title":"Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica","volume":"54","author":"Randall","year":"2004"},{"key":"ref30","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.44.1.10-13.2000","article-title":"Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump","volume":"44","author":"Oethinger","year":"2000"},{"key":"ref31","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1128\/AAC.43.6.1340","article-title":"Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa","volume":"43","author":"Lomovskaya","year":"1999"},{"key":"ref32","series-title":"Microb Drug Resist","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/10766290260469543","article-title":"The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204","volume":"8","author":"Baucheron","year":"2002"},{"key":"ref33","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/AAC.47.1.390-394.2003","article-title":"In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump","volume":"47","author":"Luo","year":"2003"},{"key":"ref34","series-title":"J Bacteriol","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1128\/JB.183.20.5803-5812.2001","article-title":"Analysis of the complete library of putative drug transporter genes in Escherichia coli","volume":"183","author":"Nishino","year":"2001"},{"key":"ref35","series-title":"J Bacteriol","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1128\/JB.182.6.1754-1756.2000","article-title":"AcrD of Escherichia coli is an aminoglycoside efflux pump","volume":"182","author":"Rosenberg","year":"2000"},{"key":"ref36","series-title":"J Mol Microbiol Biotechnol","first-page":"225","article-title":"Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria","volume":"3","author":"Lomovskaya","year":"2001"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/72\/1\/ajvr.72.1.25.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/72\/1\/ajvr.72.1.25.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/72\/1\/ajvr.72.1.25.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:25:59Z","timestamp":1741350359000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/72\/1\/ajvr.72.1.25.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":36,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.72.1.25","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}